Dr. Maxwell Allen Braverman, DO

Dr. Braverman practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Braverman's NPI, 1346683018, was assigned on April 12, 2013. Dr. Braverman graduated from Arizona College of Osteopathic Medicine - Glendale in 2013. Dr. Braverman holds Texas license R5517.

Dr. Braverman's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Braverman's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Braverman is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Braverman to 5 more hospitals, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Braverman practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Braverman's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Braverman is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Braverman's licenses on file in 2 states: Texas and Delaware.

Dmand AI lists acute gallbladder or bile duct inflammation, chest trauma, collapsed lung, colon removal, gastrointestinal obstruction, multiple traumatic injuries, non-surgical back problems and traumatic coma among the conditions Dr. Braverman treats.

CMS data shows 567 Medicare services from Dr. Braverman across 11 procedure codes in 2024, for 407 Medicare patients. Medicare paid $52,107 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 407 Medicare patients who saw Dr. Braverman in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Braverman's median patient age at 74, with 51% women.

In 2016, Dr. Braverman wrote 13 Medicare Part D claims. They cover 1 drug, with $126 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Braverman for performance year 2024, reported through an alternative payment model (APM). Dr. Braverman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Braverman, published from 2020 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Wounds and Injuries, Blood Transfusion and Resuscitation. Dr. Braverman has published most often in Transfusion. Dr. Braverman's most frequent co-authors are Donald Howard Jenkins, MD, Susannah E. Nicholson, MD and Steven Gremel Schauer, DO.

CMS Open Payments shows 22 general payments to Dr. Braverman from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Acell, Inc. paid the most, $1,050.

Dr. Braverman graduated from Arizona College of Osteopathic Medicine - Glendale in 2013.

Dr. Braverman is in network with 24 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.